Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
prolonging spray.
Popular Articles

Family Drug Support's 'Stepping Stones To Success' Wins At The 2009 National Drug And Alcohol Awards
Family Drug Support"s Stepping Stones to Success program has won the 2009 National Drug and Alcohol Award for Excellence in Prevention and Community Education.
generic viagra
Discovery Of Active Genes In The Developing Mammal Brain
A study by scientists at Penn State provides new information about the genes that are involved in a mammal"s early brain development, including those that contribute to neurological disorders. The study is the first to use high-throughput sequencing to uncover active genes in developing brains, and it is likely the best evidence thus far for the activity in the brain of such a large number of genes. The research results one day could lead to the development of drugs or gene therapies that treat neurological disorders such as autism and mental retardation. The research, which was led by Distinguished Professor of Biology Hong Ma and Associate Professor of Biology Gong Chen, will be published online in the Early Edition of the Proceedings of the National Academy of Sciences sometime during the week of 13 July 2009.
Zubni implantati
News of the day
Stem Cell Therapeutics Corp. Announces Publication Of Phase I Stroke Data
Stem Cell Therapeutics Corp. ("SCT" or the "Company") (TSX VENTURE:SSS) is pleased to announce the acceptance and publication of the paper entitled "Open labeled, uncontrolled pharmacokinetic study of single intramuscular hCG dose in healthy male volunteers" by the International Journal of Clinical Pharmacology and Therapeutics, Vol. 47, August 2009. This paper was authored by Drs. Alan Moore, President & CEO, Allen Davidoff, VP Product Development and Yan Yang, Clinical Research Associate, all of SCT; Dr. Michael D. Hill of Foothills Hospital at the University of Calgary, and Dr. Steven C. Cramer, from the University of California, Irvine.
Cardiovascular

NPS RADAR Reviews Rivaroxaban - Oral Anticoagulant For Post-knee Replacement Surgery, Australia

Prescribers treating patients who have had total hip or knee replacement surgery can access an independent review of the oral anticoagulant rivaroxaban (Xarelto) in the August issue of NPS RADAR. NPS RADAR provides independent information about new medicines and changes to PBS listings to health professionals and is published to coincide with PBS updates, giving health professionals access to information when they need it. "GPs and pharmacists may see patients who have been initiated on rivaroxaban in hospital. They should be aware that rivaroxaban has only been evaluated for use in preventing deep vein thrombosis and pulmonary embolism after elective total hip or total knee replacement surgery," NPS senior adviser, quality use of medicines, Judith Mackson said. "Duration of the therapy is 14 days after knee replacement or 35 days after hip replacement and no longer. Some patients will need a GP prescription soon after discharge to cover the remaining duration of therapy. GPs will need to take into account the number of tablets the hospital has provided when selecting a suitable pack size and instructing the patient on how many tablets to take." Dose adjustment and titration, and monitoring of prothrombin time are not required. As with other anticoagulants, managing the risk of bleeding is a primary concern, and patients should be alert to possible signs of bleeding. "Prescribers should be aware that there are only small differences in efficacy and safety between rivaroxaban, low molecular weight heparins (Clexane and Fragmin), fondaparinux (Arixtra) and dabigatran (Pradaxa)," Ms Mackson said. Other topics covered in the latest edition of NPS RADAR include: - Hydromorphone prolonged-release tablets (Jurnista) for chronic severe disabling pain - Oxybutynin patch (Oxytrol) PBS listed as an alternative for overactive bladder - Update on PBS listings for Aboriginal peoples and Torres Strait Islanders - Sitagliptin with metformin - (Janumet) fixed-dose combination tablets PBS listed for type 2 diabetes mellitus - Risedronate (Actonel Once-a-month) and summary of anti-resorptive drug listings - Lanthanum (Fosrenol) tablets for adults with chronic kidney disease who are on dialysis http://www.nps.org.au/radar National Prescribing Service.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009